Pharma channel feed

EMA makes rec­om­men­da­tions to man­u­fac­tur­ers as it aims to stem drug short­ages

Last year
Manufacturing

Pfiz­er shakes up agency ros­ter un­der new mar­ket­ing chief

Last year
Marketing

As­traZeneca push­es Tagris­so-chemo com­bo fol­low­ing pos­i­tive pro­gres­sion-free sur­vival da­ta

Last year

The FTC just went af­ter 'bundling' in Am­gen's $28B deal. Will it put a chill on fu­ture M&A?

Last year

FDA ap­proves Al­ler­gan's newest hyaluron­ic acid in­jectable — with a new de­liv­ery sys­tem

Last year
FDA+

Pod­cast ad spend­ing ris­es among phar­ma com­pa­nies, as the au­dio chan­nel booms across in­dus­tries

Last year
Marketing

Post-re­call, OTC eye drop mak­er hand­ed a warn­ing let­ter from the FDA

Last year
Manufacturing

Ip­ca Lab­o­ra­to­ries cit­ed for qual­i­ty is­sues at In­dia fa­cil­i­ty that pro­duces API

Last year
Manufacturing

FDA sig­nals sup­port for Pfiz­er’s RSV shot in ad­comm docs be­fore cru­cial vote

Last year
FDA+

Mar­ket­ingRx roundup: Phar­ma ad boost on YouTube; Mer­ck re-ups lung can­cer test so­cial ad­vo­ca­cy

Last year
Marketing

Di­a­betes and obe­si­ty ex­perts on so­cial me­dia call emerg­ing class of drugs ‘game chang­ers’ — Har­ris Poll

Last year
Marketing

As­traZeneca is leav­ing the lob­by­ing group PhRMA, third drug­mak­er to ditch trade group in last five months

Last year

Bay­er launch­es 'See­ing Red' cam­paign to raise aware­ness for Mire­na's use in heavy pe­ri­ods

Last year
Marketing

Bay­er cuts four pro­grams amid a 's­low start' to the year

Last year

Talc claimants look to sue J&J over al­leged fraud in bank­rupt­cy case

Last year
Law

Mod­er­na goes af­ter Al­ny­lam, fil­ing coun­ter­claims in Spike­vax patent suit

Last year
Law

New Alzheimer's drugs from Ei­sai and Lil­ly: Ex­pec­ta­tions set at $10B+ in com­bined sales by 2030

Last year

As­traZeneca changes up asth­ma cam­paign, moves to high­light con­trol for hard-to-con­trol sub­type

Last year
Marketing

FDA ad­comm backs ac­cel­er­at­ed ap­proval of Sarep­ta's Duchenne gene ther­a­py in close vote

Last year
R&D
FDA+

Vi­iV Health­care spot­lights the pow­er of moth­er and son re­la­tion­ships in new cam­paign

Last year
Marketing

Ab­b­Vie sues drug cost sav­ings com­pa­ny over al­leged fraud­u­lent use of pa­tient as­sis­tance pro­gram

Last year
Law

GAO: 340B pro­gram net­ted sav­ings and pro­vid­ed ben­e­fits for low-in­come pa­tients

Last year

Astel­las wins ap­proval for menopause hot flash treat­ment Veozah

Last year
FDA+

Judge triples Eli Lil­ly's pay­out in Med­ic­aid re­bate case to $183M+

Last year
Law
First page Previous page 122123124125126127128 Next page Last page
A service from the Financial Times